Patent · US Active

MGluR5 modulators I

US7678796B2 · kind B2 · utility

1Cited by

0References

21Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Andreas Wallberg · Timrå, SE
Karolina Nilsson · Gately Drive, SE
Bjorn Holm · Timrå, SE
Mats Nagard · Mölndal, SE
Kenneth Granberg · Mölndal, SE
Abdelmalik Slassi · Mississauga, CA
Louise Edwards · Mississauga, CA
Methvin Isaac · Toronto, CA
Tao Xin · Vaughan, CA
Tomislav Stefanac · Toronto, CA

Key dates

Filing date	Apr 25, 2007
Grant date	Mar 16, 2010
Priority date	—
Expiry date	May 23, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.